SWOT Analysis for Iterum Therapeutics Plc

Rising Net Cash Flow and Cash from Operating activity
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Annual Net Profits improving for last 2 years
Stock with Low PE (PE < = 10)
Volume Shockers

New 52 week low today
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
RSI indicating price weakness
Near 52 Week Low
Stocks Underperforming their Industry Price Change in the Quarter

Red Flags: Weakening Technicals and Share Price Decline
MFs decreased their shareholding last quarter
Institutions decreased their shareholding last quarter

Iterum Therapeutics Plc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats